<![CDATA[Delta-Fly Pharma, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=44951>Sun, 15 Mar 2026 20:10:24 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Delta-Fly Pharma Inc.: Notice of initiation of patients enrollment in Phase III Pivotal comparative clinical trial of DFP-14323]]>https://www.newswire.co.kr/newsRead.php?no=992779Thu, 04 Jul 2024 10:50:00 +0900<![CDATA[델타플라이파마, DFP-14323의 제3상 확증 비교 임상시험에 환자 등록 개시 고지]]>https://www.newswire.co.kr/newsRead.php?no=992781Thu, 04 Jul 2024 10:50:00 +0900<![CDATA[델타플라이파마 DFP-14323의 제3상 중추적 비교 임상시험 개시 고지]]>https://www.newswire.co.kr/newsRead.php?no=983746Sun, 04 Feb 2024 11:05:33 +0900<![CDATA[Delta-Fly Pharma Inc.: Notice of Initiation of Phase III Pivotal comparative clinical trial of DFP-14323]]>https://www.newswire.co.kr/newsRead.php?no=983745Sun, 04 Feb 2024 11:00:53 +0900